NASDAQ:AMPE - Ampio Pharmaceuticals Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Ampio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.62 -0.03 (-4.60 %) (As of 02/24/2020 11:14 AM ET) Add Compare Today's Range$0.60Now: $0.62▼$0.6550-Day Range$0.58MA: $0.67▼$0.7352-Week Range$0.26Now: $0.62▼$1.31Volume384,218 shsAverage Volume1.28 million shsMarket Capitalization$98.79 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartEarningsInstitutional OwnershipHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds. Its product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee. Ampio Pharmaceuticals, Inc. is headquartered in Englewood, Colorado. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:AMPE Previous Symbol CUSIPN/A CIKN/A Webhttp://www.ampiopharma.com/ Phone720-437-6500Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees22 Outstanding Shares158,645,000Market Cap$98.79 million Next Earnings Date3/16/2020 (Estimated) OptionableOptionable Receive AMPE News and Ratings via Email Sign-up to receive the latest news and ratings for AMPE and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:AMPE Rates by TradingView Ampio Pharmaceuticals (NASDAQ:AMPE) Frequently Asked Questions What is Ampio Pharmaceuticals' stock symbol? Ampio Pharmaceuticals trades on the NASDAQ under the ticker symbol "AMPE." When is Ampio Pharmaceuticals' next earnings date? Ampio Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Ampio Pharmaceuticals. What is the consensus analysts' recommendation for Ampio Pharmaceuticals? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ampio Pharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ampio Pharmaceuticals. Has Ampio Pharmaceuticals been receiving favorable news coverage? Press coverage about AMPE stock has trended negative recently, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Ampio Pharmaceuticals earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an effect on the stock's share price in the near term. View News Stories for Ampio Pharmaceuticals. Who are some of Ampio Pharmaceuticals' key competitors? Some companies that are related to Ampio Pharmaceuticals include Pfenex (PFNX), TELIX Pharmaceutical (TLX), Trillium Therapeutics (TRIL), Biotest (BIO), Silence Therapeutics (SLN), Rafael (RFL), ProMetic Life Sciences (PLI), IMV (IMV), Resverlogix (RVX), Theratechnologies (TH), Neuren Pharmaceuticals (NEU), Horizon Discovery Group (HZD), Emblem (EMC), IMV (IMV) and Monash IVF Group (MVF). What other stocks do shareholders of Ampio Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ampio Pharmaceuticals investors own include Strongbridge Biopharma (SBBP), Acasti Pharma (ACST), Agile Therapeutics (AGRX), Applied Genetic Technologies (AGTC), Chiasma (CHMA), Endo International (ENDP), Genocea Biosciences (GNCA), OncoCyte (OCX), Veru (VERU) and vTv Therapeutics (VTVT). Who are Ampio Pharmaceuticals' key executives? Ampio Pharmaceuticals' management team includes the folowing people: Mr. Michael E. Macaluso, Founder, Chairman & CEO (Age 67)Ms. Holli Cherevka, Chief Operating Officer (Age 36)Mr. Daniel G. Stokely, CFO & Corp. Sec. (Age 55)Lane Hapke, VP of Manufacturing OperationsApril Ramirez, Clinical Trial Mang. How do I buy shares of Ampio Pharmaceuticals? Shares of AMPE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Ampio Pharmaceuticals' stock price today? One share of AMPE stock can currently be purchased for approximately $0.62. How big of a company is Ampio Pharmaceuticals? Ampio Pharmaceuticals has a market capitalization of $98.79 million. Ampio Pharmaceuticals employs 22 workers across the globe.View Additional Information About Ampio Pharmaceuticals. What is Ampio Pharmaceuticals' official website? The official website for Ampio Pharmaceuticals is http://www.ampiopharma.com/. How can I contact Ampio Pharmaceuticals? The company can be reached via phone at 720-437-6500. MarketBeat Community Rating for Ampio Pharmaceuticals (NASDAQ AMPE)Community Ranking: 3.3 out of 5 ( )Outperform Votes: 4 (Vote Outperform)Underperform Votes: 2 (Vote Underperform)Total Votes: 6MarketBeat's community ratings are surveys of what our community members think about Ampio Pharmaceuticals and other stocks. Vote "Outperform" if you believe AMPE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMPE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/24/2020 by MarketBeat.com StaffFeatured Article: What is the Beige Book?
